Novo Nordisk (NVO.US) was first covered by the Bank of Montreal in Canada, giving it an superior market rating, with a target price of $163.00.
Novo Nordisk(NVO.US)获加拿大蒙特利尔银行首次覆盖，给予优于大市评级, 目标价163.00美元。
Novo Nordisk (NVO.US) was first covered by the Bank of Montreal in Canada, giving it an superior market rating, with a target price of $163.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.